Participated · Series A · Jun 2026

Evotrex develops hybrid extended-range electric travel trailers designed to enable extended off-grid living. Its first model, the PG5, is an EREV with a battery pack recharged by an onboard gas engine, and the company revealed a functional version at CES after emerging from stealth. The PG5’s Premium trim is priced around $160,000, and Evotrex says 90% of its existing order book is for that fully loaded trim. The company plans to target roughly 1,000 units annually once production ramps and will manufacture in China with final assembly in California. Evotrex has prioritized service capability early—hiring its first service employee six months ago and bringing on its first sales hire more recently—as it spends the next 10–12 months on durability testing. The startup has raised $46 million to date and is using the new capital to complete testing, finalize manufacturing plans, and prepare for deliveries.

Led · Equity · Jun 2023

Carbonwave (d/b/a C-Combinator) develops ultra-regenerative advanced biomaterials from Sargassum seaweed using a cascading biorefinery model. Its proprietary technologies upcycle oversupplied Sargassum into high‑value biomaterials while removing toxic and reef‑damaging substances and sequestering greenhouse gases. The company positions its products as replacements for petroleum‑based products and other harmful industrial inputs, aiming to support coastal ecosystem resilience. Carbonwave says its operations create employment, foster eco‑tourism, and support marine protected areas while improving coastal community health and safety. Management intends to grow new product lines and expand into new geographies with investor support. The company received an investment of up to $6 million to support scaling of its biorefinery; no revenue or user metrics were disclosed in the article. Carbonwave collects and processes sargassum to produce a liquid fertilizer, a seaweed-based emulsifier for cosmetics, and pulp for faux leather. It uses a proprietary extraction process that presses the seaweed and removes arsenic, yielding a liquid fertilizer and leftover pulp for other products. The company says its sargassum fertilizer reduces the need for nitrogen fertilizer. Carbonwave has already sold half a ton of its emulsifier and plans to scale production. The startup recently raised $5 million to help scale emulsifier production and said it may top up the Series A later. To date it has secured at least $12 million and is backed by ESG-focused and ocean-focused investors. C-Combinator removes rotting, methane-emitting seaweed from Caribbean beaches and turns it into sustainable products. The company has primarily financed operations through convertible notes from family offices and angel investors, with individual checks typically between $50,000 and $250,000. Chapin says those notes have amounted to almost $4 million raised to date. Crowdfunding constitutes roughly 5% of the company’s funding and is used partly to build a base of global supporters around the brand. One of C-Combinator’s largest backers is the venture arm of a family office, Baruch Future Ventures. The founder bypassed traditional VC partly because he felt few VCs were well positioned to back the mission and to avoid surrendering substantial equity.

Led · Seed · Jun 2016

LinkBee is an IoT smart home company centered on proprietary LED light bulbs and sensors that leverage environmental feedback and intelligent, self-learning algorithms to enhance the home environment. The company is led by CEO Dr. Jason Slosberg and was founded in early 2015. LinkBee plans to deploy its solution in select cities later this year and to launch nationally in 2017. It intends to use the funds to accelerate product development and expand its team in the Bay Area. The company is based in New York City and Sunnyvale, California. LinkBee closed a $6M seed funding round to advance its platform and commercial rollout.

Led · Equity · Mar 2016

PanTheryx Inc. is a Boulder-based life-sciences company that produces health products derived from bovine colostrum. Colostrum contains antibodies and nutrients required for a newborn animal to receive passive immunity to diseases. The company recently raised more than $52 million from investors in a fundraising tied to a Form D filing. The offering associated with that filing totaled $60 million. PanTheryx previously raised nearly $50 million from investors in 2019. Since its founding in 2009, the company has raised more than $190 million, according to Crunchbase. PanTheryx develops novel medical foods, biologics and nutritionals aimed at treating serious GI conditions such as C. difficile infection, Crohn’s disease and ulcerative colitis, and managing GI side effects of cancer therapies. The company’s candidates are built on bioactive backbones that contain multiple molecules with complementary mechanisms of action rather than single-target de novo molecules. Its existing product line includes the flagship nutritional DiaResQ, and it operates production facilities in Phoenix, AZ and Ripon, CA. PanTheryx intends to use recent financing to accelerate development of its pipeline and to expand its nutritionals business. The company was founded in 2007 by Mark Braman, who serves as CEO. The articles report total financing to date of $170 million following the most recent round. PanTheryx develops and commercializes medical nutrition products that target the gastrointestinal microbiome. Its flagship product, DiaResQ, addresses acute infectious diarrhea, a leading cause of death among children under five. DiaResQ is available in the United States on Amazon and at Passport Health clinics and was named in the Reimagining Global Health report as a leading healthcare innovation for 2030. The company plans to use recent financing proceeds to support a global commercial launch of DiaResQ, accelerate research and development, and pursue strategic initiatives including acquisitions. PanTheryx has expanded commercial and global health capabilities via a multi-country supply and licensing agreement with Dr. Reddy’s and by hiring Dr. Mark Grabowsky to direct relations with health agencies and NGOs. Founded in 2007 and based in Boulder, Colorado, PanTheryx leverages a proprietary technology platform to advance medical nutrition interventions.

Participated · Seed · Jul 2013

The IdeaLists is an online marketplace that connects the marketing needs of projects and clients with curated solutions from professional individuals and full‑service agencies based on schedule, budget and deliverables. Founded by Adam Glickman and based in Los Angeles, the platform matches clients to curated creative talent. The startup currently claims a community of over 5,000 members. It raised $1.7M in seed funding to support growth. Backers include Double M Capital, Pegasus Capital, Siemer Ventures, 500 Startups, Clark Landry, Paul Bricault and others. The company intends to use the funds to continue developing the platform and increase its sales and marketing efforts.